Unravelling how protein signalling networks integrate to control T cell fate [ 2018 - ]

Research Grant

Researchers: Dr Julia Marchingo (Principal investigator)

Brief description Rational design of drug combinations to manipulate the immune response requires an understanding of how different signals work together to control cell behaviour. The PIM kinase proteins are known to regulate important properties of immune cells, including division and death and when dysregulated can lead to cancer. I will perform a comprehensive, unbiased investigation of how the PIM kinases interact with other protein signalling pathways to control the immune response in health and disease.

Funding Amount $408,768.00

Funding Scheme Early Career Fellowships

Notes CJ Martin Biomedical ECF